9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk
Key Takeaways
- Atrial fibrillation shows no discrete P waves and an irregularly irregular ventricular response; typical atrial flutter shows sawtooth waves at about 250-350 beats per minute.
- Counterclockwise typical flutter produces negative sawtooth waves in II, III, and aVF with a positive flutter wave in V1; clockwise flutter reverses both.
- AF classification is paroxysmal (terminates within 7 days), persistent (over 7 days), long-standing persistent (over 12 months), and permanent (a decision to stop rhythm control).
- Ectopy from myocardial sleeves in the pulmonary veins triggers most paroxysmal atrial fibrillation, which is why pulmonary vein isolation is the cornerstone ablation.
- Irregularly irregular wide complexes at rates above 250 beats per minute with varying QRS morphology indicate pre-excited atrial fibrillation and prohibit AV nodal blocking drugs.
9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk
Atrial fibrillation is the most common sustained arrhythmia in adults and the reason most EP labs are busy. CCI tests it through ECG/EGM rhythm analysis and interpretation, cardiac pathophysiology, and indications for ablation procedures in the knowledge list, and through tasks C4 and D2-D4.
1. Atrial Fibrillation on the ECG
| Feature | Finding |
|---|---|
| P waves | Absent — replaced by chaotic fibrillatory (f) waves at 400-600/min |
| Ventricular response | Irregularly irregular, classically 100-180 bpm untreated |
| QRS | Narrow unless aberrancy, bundle branch block, or pre-excitation |
| Baseline | Coarse or fine undulation; fine AF can look deceptively flat |
Irregular irregularity with no discernible P waves is the diagnosis. Two mimics must be excluded: multifocal atrial tachycardia (irregular but with ≥ 3 distinct P-wave morphologies and measurable PR intervals) and atrial flutter with variable block (irregular but with organized, constant-rate flutter waves).
Ashman phenomenon describes an aberrantly conducted beat following a long-short RR sequence — the long cycle lengthens refractoriness, so the next early beat finds the right bundle refractory and conducts with an RBBB pattern. It is a benign functional phenomenon, not ventricular ectopy.
An entirely regular ventricular response during known atrial fibrillation is abnormal and means either complete AV block with a junctional or ventricular escape (classically digoxin toxicity) or a paced/regularized rhythm.
2. Atrial Flutter
Atrial flutter is a macroreentrant atrial tachycardia — a wavefront circulating around an anatomic obstacle with an excitable gap — which is exactly why it can be entrained and ablated with a line.
Typical (cavotricuspid isthmus-dependent) flutter
The circuit runs around the tricuspid annulus, constrained anteriorly by the annulus and posteriorly by the crista terminalis and Eustachian ridge, passing through the cavotricuspid isthmus between the tricuspid annulus and the inferior vena cava.
| Counterclockwise (typical, ~90%) | Clockwise (reverse typical) | |
|---|---|---|
| Circuit direction (LAO view) | Counterclockwise around the tricuspid annulus | Clockwise |
| Leads II, III, aVF | Negative sawtooth flutter waves | Positive, broader flutter waves |
| Lead V1 | Positive (upright) flutter wave | Negative |
| Septal activation | Caudocranial (up the septum) | Craniocaudal |
| Atrial rate | ~250-350 bpm (typically ~300) | Same |
Because the atrial rate is near 300 with 2:1 AV conduction, the classic presentation is a regular narrow-complex tachycardia at almost exactly 150 bpm — the single most useful pattern-recognition cue in bedside EP. Any regular narrow tachycardia at 150 should prompt a hunt for flutter waves, using vagal maneuvers or adenosine to increase AV block and unmask them.
Both directions use the same isthmus, so both are cured by the same cavotricuspid isthmus line.
Atypical flutter
Any macroreentrant atrial tachycardia not dependent on the cavotricuspid isthmus: peri-mitral flutter around the mitral annulus, roof-dependent left atrial flutter, scar-related circuits after cardiac surgery or prior ablation, and upper-loop right atrial reentry. Atypical flutter is common after atrial fibrillation ablation because prior lesion sets create the required barriers, and it requires activation and entrainment mapping to define the circuit rather than a standard anatomic line.
3. Classification and Pathophysiology of Atrial Fibrillation
| Category | Definition |
|---|---|
| Paroxysmal | Terminates spontaneously or with intervention within 7 days of onset |
| Persistent | Sustained beyond 7 days |
| Long-standing persistent | Continuous for more than 12 months with a rhythm-control strategy still pursued |
| Permanent | A joint clinical decision to stop pursuing sinus rhythm — a decision, not an electrophysiologic state |
Note that permanent AF is defined by intent, not by the arrhythmia, and reclassifies if the decision changes. Contemporary staging frameworks also recognize risk-factor and pre-clinical stages preceding clinical AF, reflecting the shift toward treating obesity, sleep apnea, alcohol use, hypertension, and deconditioning as part of rhythm management.
Mechanism. Two components combine:
- Triggers — rapidly firing ectopic foci, most arising from myocardial sleeves extending from the left atrium into the pulmonary veins, longest in the superior veins. This is the observation that created pulmonary vein isolation. Non-pulmonary-vein triggers include the superior vena cava, coronary sinus, ligament of Marshall, crista terminalis, and left atrial appendage.
- Substrate — atrial stretch, fibrosis, inflammation, and shortened refractoriness that let multiple wavelets or rotors sustain the arrhythmia. AF begets AF: electrical and structural remodeling from ongoing fibrillation makes subsequent episodes easier to sustain, which is the rationale for early rhythm control.
Consequences: loss of the atrial contribution to filling (roughly 20-30% of cardiac output, worst in a stiff ventricle), stasis in the left atrial appendage producing thromboembolism, and tachycardia-induced cardiomyopathy with poorly controlled rates.
4. Management Framework
Rate control targets a resting ventricular rate typically below 110 bpm in an asymptomatic patient (lenient) or below 80 bpm when symptoms persist (strict), using beta blockers, non-dihydropyridine calcium channel blockers, or digoxin — with the caveat that digoxin's vagal mechanism fails during exertion.
Rhythm control uses antiarrhythmic drugs, cardioversion, or catheter ablation. Trial evidence supports early rhythm control in recently diagnosed AF, and catheter ablation is superior to antiarrhythmic drugs for maintaining sinus rhythm, particularly in paroxysmal AF and in AF with heart failure and reduced ejection fraction, where ablation improves outcomes.
Cardioversion timing and anticoagulation is a rule-based area the exam favors:
| Scenario | Requirement |
|---|---|
| AF < 48 h duration, low risk | Cardiovert with anticoagulation started at presentation |
| AF ≥ 48 h or unknown duration | 3 weeks of therapeutic anticoagulation before, or a TEE to exclude appendage thrombus, then cardiovert |
| Any cardioversion | ≥ 4 weeks of anticoagulation afterward because of atrial stunning |
| Hemodynamic instability | Cardiovert immediately, anticoagulate as soon as feasible |
AV junction ablation with pacing ("ablate and pace") is the last-resort rate-control strategy for refractory symptomatic AF: the AV junction is ablated deliberately, creating permanent complete heart block, and the patient becomes absolutely pacemaker-dependent. It controls rate and regularizes the rhythm but does not eliminate atrial fibrillation or the need for anticoagulation.
5. Pre-Excited Atrial Fibrillation — the Emergency
When atrial fibrillation occurs in a patient with a manifest accessory pathway, the pathway's non-decremental, fast-response conduction transmits the chaotic atrial rate directly to the ventricle.
Recognition:
- Irregularly irregular rhythm
- Wide QRS complexes with varying morphology (fusion between pathway and AV nodal conduction beat to beat)
- Very rapid rate, often 250-300+ bpm, with the shortest pre-excited RR interval being the key risk marker (≤ 250 ms indicates a high-risk pathway)
Management:
| Do | Never |
|---|---|
| Immediate synchronized cardioversion if unstable | Adenosine |
| Procainamide or ibutilide if stable | Verapamil or diltiazem |
| Prompt referral for accessory pathway ablation | Digoxin |
| Beta blockers (AV nodal blockade) | |
| Amiodarone IV (AV nodal effect; now avoided in this setting) |
The mechanism of harm is uniform: every prohibited agent blocks the AV node, removing the only limiting pathway and channelling the entire atrial rate down the accessory pathway, accelerating the ventricular response into ventricular fibrillation. This single scenario appears on nearly every EP-oriented certification exam, and the correct instinct is to reach for cardioversion or a sodium channel blocker rather than for the familiar rate-control drugs.
A regular narrow-complex tachycardia at 148 beats per minute is unchanged by vagal maneuvers. After 6 mg of adenosine the ventricular rate transiently falls and organized negative sawtooth deflections appear in leads II, III, and aVF with an upright deflection in V1 at 296 per minute. What is the rhythm and its circuit?
A 26-year-old arrives with an irregularly irregular tachycardia at 270 beats per minute with wide QRS complexes of continuously varying morphology. Blood pressure is 96/58 mmHg and the patient is alert. Which management is correct?
A patient with atrial fibrillation of unknown duration and a CHA2DS2-VASc score of 3 is hemodynamically stable and scheduled for elective cardioversion. What is required before the shock?